Carnosic acid protects against mitochondrial dysfunction and ferroptosis in myocardial ischemia/reperfusion injury through mediating Mfn2
European Journal of Pharmacology · 2026
DOI: 10.1016/j.ejphar.2026.178690 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Xiu-Qi Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China. Hauptthemen laut MEDLINE: Abietanes, Ferroptosis, Myocardial Reperfusion Injury, GTP Phosphohydrolases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
The pathogenesis of myocardial ischemia/reperfusion injury (MIRI) is complicated and involves various factors, including iron overload, oxidative stress, mitochondrial damage, calcium overload, and inflammation. Hence, the aim of this study was to explore the molecular mechanisms of MIRI and verify the myocardial protection mechanism of carnosic acid (CA) in MIRI. In vivo and in vitro MIRI models were established. The results of this study verified that pretreatment with CA effectively increased cell viability, reduced the apoptosis rate and lactate dehydrogenase activity, maintained mitochondrial dynamic balance, and inhibited iron overload and abnormal lipid metabolism in cardiomyocytes with anoxia/reoxygenation treatment. Pretreatment with CA not only improved cardiac function and reduced infarct size in rats treated with ischemia/reperfusion (I/R) but also decreased reactive oxygen species levels and the rate of apoptotic cardiomyocytes in myocardium induced by I/R. These cardioprotective effects of CA could be inhibited by treatment with adenoviral vector expressing Mfn2 short hairpin RNA. In general, CA pretreatment protected cardiomyocytes against MIRI injury by inhibiting ferroptosis and maintaining mitochondrial dynamic homeostasis through an Mfn2-dependent mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
- Department of Cardiovascular Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China. Electronic address: liujichun999@yeah.net.
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China. Electronic address: ndyfy03743@ncu.edu.cn.
Förderung
- Jiangxi Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Wang, X. Q., Hu, F. J., Huang, H., Zou, C. C., Yuan, Y., Qiao, Y. M., Liu, L. X., Zou, H. X., Liu, J. C., & Lai, S. Q. (2026). Carnosic acid protects against mitochondrial dysfunction and ferroptosis in myocardial ischemia/reperfusion injury through mediating Mfn2. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.178690
Vancouver
Wang XQ, Hu FJ, Huang H, Zou CC, Yuan Y, Qiao YM, et al. Carnosic acid protects against mitochondrial dysfunction and ferroptosis in myocardial ischemia/reperfusion injury through mediating Mfn2. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2026.178690
BibTeX
@article{Wang2026,
author = {Wang, Xiu-Qi and Hu, Fa-Jia and Huang, Huang and Zou, Chen-Chao and Yuan, Yong and Qiao, Ya-Mei and Liu, Lan-Xiang and Zou, Hua-Xi and Liu, Ji-Chun and Lai, Song-Qing},
title = {Carnosic acid protects against mitochondrial dysfunction and ferroptosis in myocardial ischemia/reperfusion injury through mediating Mfn2},
journal = {European Journal of Pharmacology},
year = {2026},
doi = {10.1016/j.ejphar.2026.178690}
}
EUVIMED